ESC Premium Access

A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study

Congress Presentation

About the speaker

Doctor Stylianos Tzeis

Mitera Hospital, Athens (Greece)
8 presentations

3 more presentations in this session

State of the Art from history to future of anti-arrhythmic drugs

Speaker: Professor J. Camm (London, GB)


Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome

Speaker: Doctor A. Mazzanti (Pavia, IT)


Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

Speaker: Doctor M. Mihajlovic (Belgrade, RS)


Access the full session

Anti-arrhythmic drug therapy: new concepts on old drugs

Speakers: Doctor S. Tzeis, Professor J. Camm, Doctor A. Mazzanti, Doctor M. Mihajlovic

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb